KATINKO

This brand name is authorized in Hong Kong

Active ingredients

The drug KATINKO contains a combination of these active pharmaceutical ingredients (APIs):

1 Camphora
UNII 213N3S8275 - CAMPHOR, (-)-
Read about Camphora
2 Eucalyptus oil
UNII 2R04ONI662 - EUCALYPTUS OIL

When the vapour is inhaled eucalyptus oil acts to ventilate the bronchial passages and relieve bronchitis and associated conditions. It is also a rubefacient.

Read about Eucalyptus oil
3 Menthol
UNII L7T10EIP3A - MENTHOL, UNSPECIFIED FORM
Read about Menthol
4 Methyl salicylate
UNII LAV5U5022Y - METHYL SALICYLATE

Methyl salicylate has the action of salicylates, causing dilation of the skin vessels. Methyl salicylate is used to prevent bed sores and for hardening the skin of the feet.

Read about Methyl salicylate

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: HK Department of Health Drug Office Identifier(s): 64076

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.